pid,type,title,authors,mentors,source_title,published_date,url,doi,isbn,issn,eissn pharma:3062,thesis,"Usporedba određivanja brzine sedimentacije eritrocita na automatskom analizatoru SRS 100/II i ručno modificiranom Westergren metodom","Oroz, Helena",,,,,,,, sfzg:2457,"journal article","Changes in haemostasis and inflammatory markers after mRNA BNT162b2 and vector Ad26.CoV2.S SARS-CoV-2 vaccination","Ivanko, I.; Ćelap, I.; Margetić, S.; Marijančević, D.; Josipović, J.; Gaćina, P.",,,,,,,, mef:4898,"journal article","DOAC Dipstick Testing Can Reliably Exclude the Presence of Clinically Relevant DOAC Concentrations in Circulation","Margetić, Sandra; Ćelap, Ivana; Lovrenčić Huzjan, Arijana; Bosnar Puretić, Marijana; Šupraha Goreta, Sandra; Glojnarić, Anesa Čajević; Delić Brkljačić, Diana; Mioč, Pavao; Harenberg, Job; Hetjens, Svetlana; Weiss, Christel",,,,,,,, pharma:2011,thesis,"Utjecaj novih oralnih antikoagulacijskih lijekova na probirne pretrage hemostaze","Buben, Jelena",,,,,,,, kbcsm:336,"journal article","Chromogenic anti-FXa assay calibrated with low molecular weight heparin in patients treated with rivaroxaban and apixaban: possibilities and limitations","Margetić, Sandra; Ćelap, Ivana; Delić Brkljačić, Diana; Pavlović, Nikola; Šupraha Goreta, Sandra; Kobasić, Ivana; Lovrenčić-Huzjan, Arijana; Bašić Kes, Vanja",,,,,,,, kbcsm:81,"journal article","Interference of M-protein on Thrombin Time Test: A Case Report","Njegovan, Milena; Margetić, Sandra; Tešija Kuna, Andrea; Đerek, Lovorka; Ćelap, Ivana; Pavičić, Tomislav; Čaržavec, Dubravka; Gaćina, Petar",,,,,,,, pharma:1106,thesis,"Praćenje antiagregacijske terapije metodom optičke agregometrije na analitičkom sustavu Sysmex CS-2500","Kuktić, Ivona",,,,,,,, pharma:1005,thesis,"Verifikacija metoda za određivanje koncentracije novih oralnih antikoagulansa: dabigatrana, rivaroksabana i apiksabana","Kralj, Ana-Katarina",,,,,,,,